For the Inventor, By the Inventor

Enter assignee name

Glytech, Inc.

USPTO Granted Patents = 38

CIPO Patents = 65

EPO Patents = 30

Forward Citations = 71

Loading Chart...

Loading Chart...

90 inventors (with patents filed for the assignee):

Yasuhiro Kajihara (12 out of 25 patents)

Daniel C Javitt (9 out of 19 patents)

Kazuhiro Fukae (9 out of 17 patents)

4. Hirofumi Ochiai (7 out of 7 patents)

5. Izumi Sakamoto (7 out of 8 patents)

6. Masatoshi Maeda (6 out of 13 patents)

7. Keisuke Tazuru (6 out of 6 patents)

8. Kenta Yoshida (6 out of 6 patents)

9. Taiji Shimoda (6 out of 6 patents)

10. Kazuyuki Ishii (6 out of 11 patents)

11. Katsunari Tezuka (6 out of 26 patents)

12. Takefumi Murase (5 out of 5 patents)

13. Ryo Okamoto (4 out of 4 patents)

14. Takashi Tsuji (3 out of 50 patents)

15. Hiroaki Asai (3 out of 7 patents)

38 patents: Sort by Forward Citations

1. 12269021 - Artificial protein catalyst (2025-04-08),

2. 12103947 - Methods for producing peptide thioester and peptide (2024-10-01),

3. 11969431 - Formulations for treatment of post-traumatic stress disorder (2024-04-30),

4. 11576911 - Composition and method for treatment of depression and psychosis in humans (2023-02-14),

5. 11214592 - Production method for amino-acid polymer (2022-01-04),

6. 10913763 - Method for producing sugar having sulfate group and/or phosphate group (2021-02-09),

7. 10881665 - Formulations for treatment of post-traumatic stress disorder (2021-01-05),

8. 10683341 - Albumin-sugar chain complex (2020-06-16),

9. 10660887 - Composition and method for treatment of depression and psychosis in humans (2020-05-26),

10. 10583138 - Composition and method for treatment of depression and psychosis in humans (2020-03-10),

11. 10358470 - Glycosylated polypeptide and pharmaceutical composition containing same (2019-07-23),

12. 10202469 - Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same (2019-02-12),

13. 10053499 - Polypeptide having sialylated sugar chains attached thereto (2018-08-21),

14. 10047042 - Method for producing D-form or L-form amino acid derivative having thiol group (2018-08-14),

15. 9981059 - Sugar chain-polypeptide complex (2018-05-29),

Glytech, Inc. is a biotechnology company specializing in the development of innovative therapies for glycogen storage disorders (GSDs). With a focus on enzyme replacement therapies, Glytech aims to improve the quality of life for patients suffering from rare genetic metabolic disorders by addressing the underlying mechanisms that cause GSDs. Through extensive research and collaboration with leading experts, Glytech is committed to discovering effective treatments and bringing them to market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

38 Patents

#56 in Kyoto 615-0031

#1,981 in Japan

#17,280 in the World

Glytech, Inc.

Forward Citations = 71

90 inventors:

Yasuhiro Kajihara (12 out of 25 patents)

Daniel C Javitt (9 out of 19 patents)

Kazuhiro Fukae (9 out of 17 patents)

4. Hirofumi Ochiai (7 out of 7 patents)

5. Izumi Sakamoto (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…